Vyvanse (Generic name: lisdexamfetamine dimesylate) is a once-daily, extended-release stimulant ADHD medication used primarily to treat attention deficit hyperactivity disorder (ADHD or ADD) in children ages 6 to 12. years, adolescents and adults. Vyvanse is not a narcotic, but according to the FDA, it is a federally controlled substance (CII) because it can be abused or cause dependence. It’s an amphetamine.
Vyvanse can improve focus for people with inattentive ADHD (also known as ADD) and decrease impulsivity and hyperactive behavior, hallmark symptoms of ADHD for many patients. It is not known if it is safe for children under 6 years of age. Vyvanse has been available since 2007, when the FDA approved the drug for the treatment of ADHD.
Reviews
There are no reviews yet.